The Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) released final regulations for the remote prescribing of certain drugs and telehealth access.
Originally set to take effect on February 18, 2025, the implementation date was first postponed to March 21, 2025. Under the final regulations, the deadline is now extended to December 31, 2025.
The final regulations cover new special registration processes for the remote prescribing of buprenorphine and Schedule III-V and Schedule II-V controlled substances to Veterans Health Administration health system patients in cases when practitioners have not conducted an in-person medical evaluation.